FibroGen Inc
NASDAQ:FGEN
| Market Cap (Intraday) | 3.43B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $41.23 |
| 50-Day MA | $45.39 |
| 200-Day MA | $42.67 |
FibroGen, Inc. Stock, NASDAQ:FGEN
409 Illinois Street, San Francisco, California 94158
United States of America
Phone: +1.415.978.1200
Number of Employees: 531
Description
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.